Terms: = Lymphoma AND TAL1, TCL5, 6886, ENSG00000162367, SCL, P17542, tal-1
306 results:
1. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
[TBL] [Abstract] [Full Text] [Related]
2. Williams-Beuren syndrome in pediatric T-cell acute lymphoblastic leukemia: A rare case report and review of literature.
Yang R; Ai Y; Bai T; Lu XX; He G
Medicine (Baltimore); 2024 Feb; 103(7):e36976. PubMed ID: 38363891
[TBL] [Abstract] [Full Text] [Related]
3. Suppression of super-enhancer-driven tal1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia.
Chang YS; Gills JJ; Kawabata S; Onozawa M; Della Gatta G; Ferrando AA; Aplan PD; Dennis PA
Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37800623
[TBL] [Abstract] [Full Text] [Related]
5. Characteristics and therapeutic approaches for patients diagnosed with T-ALL/LBL exhibiting t(8;14)(q24;q11)/TCRA/D:MYC translocation.
Zhang X; Wang T; Zhang Y; Wang F; Chen J; Ni J; Sun R; Wei Z; Zhang G; Li W; Li J; Lu P
Leuk Lymphoma; 2023 Dec; 64(13):2133-2139. PubMed ID: 37674391
[TBL] [Abstract] [Full Text] [Related]
6. tal1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia.
Tan SH; Tan TK; Yokomori R; Liao M; Huang XZ; Yeoh AEJ; Sanda T
Leukemia; 2023 Oct; 37(10):1969-1981. PubMed ID: 37591943
[TBL] [Abstract] [Full Text] [Related]
7. S1P-S1PR3-RAS promotes the progression of S1PR3
Zhu D; Jiang T; Ma D; Zhang H; Zhang J; Lv W; Gong M; Wang H; Liu Z; Su H; Zeng L; Liu S; Tang S; Yang B; Tshavuka FI; Fu G; Liu Z; Peng D; Liu H; Yan Z; Cao Z; Zhao H; He TC; Yu J; Shu Y; Zou L
Leukemia; 2023 Oct; 37(10):1982-1993. PubMed ID: 37591940
[TBL] [Abstract] [Full Text] [Related]
8. Spindle Cell Lipoma With Florid Primary Follicular Lymphocytic Hyperplasia: A Novel Association With Potential Diagnostic Pitfalls.
Fattah YH; Liu SS; Susa J; Hanly A; Russo J; Karai LJ
Am J Dermatopathol; 2023 Aug; 45(8):563-566. PubMed ID: 37462206
[TBL] [Abstract] [Full Text] [Related]
9. The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia.
O'Connor D; Demeulemeester J; Conde L; Kirkwood A; Fung K; Papaleonidopoulou F; Bloye G; Farah N; Rahman S; Hancock J; Bateman C; Inglott S; Mee J; Herrero J; Van Loo P; Moorman AV; Vora A; Mansour MR
J Clin Oncol; 2023 Jul; 41(19):3545-3556. PubMed ID: 37098241
[TBL] [Abstract] [Full Text] [Related]
10. [Clinical features of 19 patients with SIL-tal1-positive T-cell acute lymphoblastic leukemia].
Wang LJ; Chen Y; Xiang M; Yang XF; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):132-136. PubMed ID: 36948867
[No Abstract] [Full Text] [Related]
11. Harnessing the MYB-dependent tal1 5'super-enhancer for targeted therapy in T-ALL.
Smith C; Touzart A; Simonin M; Tran-Quang C; Hypolite G; Latiri M; Andrieu GP; Balducci E; Dourthe MÉ; Goyal A; Huguet F; Petit A; Ifrah N; Baruchel A; Dombret H; Macintyre E; Plass C; Ghysdael J; Boissel N; Asnafi V
Mol Cancer; 2023 Jan; 22(1):12. PubMed ID: 36650499
[TBL] [Abstract] [Full Text] [Related]
12. tal1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
Smith C; Goyal A; Weichenhan D; Allemand E; Mayakonda A; Toprak U; Riedel A; Balducci E; Manojkumar M; Pejkovska A; Mücke O; Sollier E; Bakr A; Breuer K; Lutsik P; Hermine O; Spicuglia S; Asnafi V; Plass C; Touzart A
Haematologica; 2023 May; 108(5):1259-1271. PubMed ID: 36632736
[TBL] [Abstract] [Full Text] [Related]
13. [Detection of Fusion Gene and Prognosis Analysis in Children with Acute Lymphoblastic Leukemia of Different Immunophenotypes].
Liu CY; Pan YS; Yang H; Hu X; Chen HY; Liu WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1673-1678. PubMed ID: 36476888
[TBL] [Abstract] [Full Text] [Related]
14. Genomic Profiling Reveals Differences in Primary Central Nervous System lymphoma and Large B-Cell lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition.
Severson EA; Haberberger J; Hemmerich A; Huang RSP; Edgerly C; Schiavone K; Najafian A; Hiemenz M; Lechpammer M; Vergilio JA; Lesser G; Strowd R; Elvin J; Ross JS; Hegde P; Alexander B; Singer S; Ramkissoon S
Oncologist; 2023 Jan; 28(1):e26-e35. PubMed ID: 36342081
[TBL] [Abstract] [Full Text] [Related]
15. A comparative analysis of low intensity ultrasound effects on living cells: from simulation to experiments.
Tamboia G; Campanini M; Vighetto V; Racca L; Spigarelli L; Canavese G; Cauda V
Biomed Microdevices; 2022 Oct; 24(4):35. PubMed ID: 36279001
[TBL] [Abstract] [Full Text] [Related]
16. Mapping the genetic features of T-ALL cases through simplified NGS approach.
García-Aznar JM; Alonso S; Iglesias DU; de Ugarriza PL; López CÁ; Balbín M; Del Castillo TB
Clin Immunol; 2022 Dec; 245():109151. PubMed ID: 36270471
[TBL] [Abstract] [Full Text] [Related]
17. Targeting dual oncogenic machineries driven by tal1 and PI3K-AKT pathways in T-cell acute lymphoblastic leukemia.
Lim FQ; Chan AS; Yokomori R; Huang XZ; Theardy MS; Yeoh AEJ; Tan SH; Sanda T
Haematologica; 2023 Feb; 108(2):367-381. PubMed ID: 36073513
[TBL] [Abstract] [Full Text] [Related]
18. Sequential Approach to Improve the Molecular Classification of Childhood Acute Lymphoblastic Leukemia.
Yu CH; Wu G; Chang CC; Jou ST; Lu MY; Lin KH; Chen SH; Wu KH; Huang FL; Cheng CN; Chang HH; Hedges D; Wang JL; Yen HJ; Li MJ; Chou SW; Hung CT; Lin ZS; Lin CY; Chen HY; Ni YL; Hsu YC; Lin DT; Lin SW; Yang JJ; Pui CH; Yu SL; Yang YL
J Mol Diagn; 2022 Nov; 24(11):1195-1206. PubMed ID: 35963521
[TBL] [Abstract] [Full Text] [Related]
19. [Characteristics and prognostic effects of NOTCH1/FBXW7 gene mutations in T-cell acute lymphoblastic leukemia patients].
Wu CY; Li YL; Dong XY; Yang SW; Shang BJ; Zhang L; Cheng W; Zhang L; Zhu ZM
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1910-1917. PubMed ID: 35768390
[No Abstract] [Full Text] [Related]
20. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
[TBL] [Abstract] [Full Text] [Related]
[Next]